Fasshauer M, Kralisch S, Klier M, Lössner U, Blüher M, Klein J, Paschke R. 2003. Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes. Biochem Biophys Res Commun 301(4):1045-1050.
Fasshauer M, Klein J, Lössner U, Klier M, Kralisch S, Paschke R. 2003. Suppression of aquaporin adipose gene expression by isoproterenol, TNFalpha, and dexamethasone. Horm Metab Res 35(4):222-227.
Fasshauer M, Klein J, Kralisch S, Lössner U, Klier M, Blüher M, Paschke R. 2003. GH is a positive regulator of tumor necrosis factor alpha-induced adipose related protein in 3T3-L1 adipocytes. J Endocrinol 178(3):523-531.
Fasshauer M, Klein J, Kralisch S, Klier M, Lössner U, Blüher M, Paschke R. 2004. Growth hormone is a positive regulator of adiponectin receptor 2 in 3T3-L1 adipocytes. FEBS Lett 558(1-3):27-32.
Fasshauer M, Kralisch S, Klier M, Lössner U, Blüher M, Chambaut-Guerin AM, Klein J, Paschke R. 2004. Interleukin-6 is a positive regulator of tumor necrosis factor alpha-induced adipose-related protein in 3T3-L1 adipocytes. FEBS Lett 560(1-3):153-157.
Fasshauer M, Kralisch S, Klier M, Lössner U, Blüher M, Klein J, Paschke R. 2004. Insulin resistance-inducing cytokines differentially regulate SOCS mRNA expression via growth factor- and Jak/Stat-signaling pathways in 3T3-L1 adipocytes. J Endocrinol 181(1):129-138.
Fasshauer M, Klein J, Kralisch S, Klier M, Lössner U, Blüher M, Paschke R. 2004. Monocyte chemoattractant protein 1 expression is stimulated by growth hormone and interleukin-6 in 3T3-L1 adipocytes. Biochem Biophys Res Commun 317(2):598-604.
Fasshauer M, Klein J, Kralisch S, Klier M, Lössner U, Blüher M, Paschke R. 2004. Serum amyloid A3 expression is stimulated by dexamethasone and interleukin-6 in 3T3-L1 adipocytes. J Endocrinol 183(3):561-567.
Quintanilla-Martinez L, Pittaluga S, Miething C, Klier M, Rudelius M, Davies-Hill T, Anastasov N, Martinez A, Vivero A, Duyster J, Jaffe E S, Fend F, Raffeld M. 2006. NPM-ALK-dependent expression of the transcription factor CCAAT/enhancer binding protein beta in ALK-positive anaplastic large cell lymphoma. Blood 108(6):2029-2036.
Klier M, Anastasov N, Hermann A, Meindl T, Angermeier D, Raffeld M, Fend F, Quintanilla-Martinez L. 2008. Specific lentiviral shRNA-mediated knockdown of cyclin D1 in mantle cell lymphoma has minimal effects on cell survival and reveals a regulatory circuit with cyclin D2. Leukemia 22:2097–2105.
Quintanilla-Martinez L, Slotta-Huspenina J, Koch I, Klier M, Hsi ED, de Leval L, Klapper W, Gesk S, Siebert R, Fend F. 2009. Differential diagnosis of cyclin D2+ mantle cell lymphoma (MCL) based on fluorescence in situ hybridization (FISH) and quantitative real-time-PCR. Haematologica 94(11):1595-1598.
Anastasov N, Klier M, Koch I, Angermeier D, Höfler H, Fend F, Quintanilla-Martinez L. 2009. Efficient shRNA delivery into B and T lymphoma cells using lentiviral vector-mediated transfer. J Hematopathol 2(1):9–19.
Anastasov N, Bonzheim I, Rudelius M, Klier M, Dau T, Angermeier D, Duyster J, Pittaluga S, Fend F, Raffeld M, Quintanilla-Martinez L. 2010. C/EBPbeta expression in ALK+ anaplastic large cell lymphomas (ALCL) is required for cell proliferation and is induced by the STAT3 signaling pathway. Haematologica [Epub ahead of print].
Bösmüller H, Haitchi-Petnehazy S, Webersinke G, Marschon R, Roithmeier F, Stummvoll W, Fehm T, Klier-Richter M, Bonzheim I, Staebler A, Fend F. 2011. Intratumoral lymphocyte density in serous ovarian carcinoma is superior to ERCC1 expression for predicting response to platinum-based therapy. Virchows Arch Jun 29. [Epub ahead of print].
